<DOC>
	<DOCNO>NCT00671424</DOCNO>
	<brief_summary>Many patient type 2 diabetes also condition treat diuretic . The patient may also treat GSK189075 diabetes . This study plan assess possible effect administer GSK189075 combination two frequently use diuretic .</brief_summary>
	<brief_title>A Study To Compare Effects Of GSK189075 In Combination With Either Furosemide Or Hydrochlorothiazide</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Furosemide</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>Healthy determine responsible experienced physician , base medical evaluation include medical history , physical examination , laboratory test , cardiac monitoring . A subject clinical abnormality laboratory parameter outside reference range population study may include Investigator GSK Medical Monitor agree find unlikely introduce additional risk factor interfere study procedure . Male subject 18 50 year age , inclusive . BMI within range 1930 kg/m2 ( inclusive ) . Capable providing sign date informed consent , include compliance requirement restriction list consent form studyspecific instruction provide site staff Significant renal disease manifest one following : Symptoms benign prostatic hyperplasia . Prostatespecific antigen level great 10ng/mL ( equivalent moderately elevate per local lab ) . Any medical procedure require ingestion radioactive agent within one week prior dose study drug . Cholecystectomy within 6 month first schedule dose study drug . Any known suspected gastrointestinal condition ( minor gastrointestinal surgery within 1 month prior first schedule dose study drug ) would likely interfere absorption transit study drug . Any subject either document cirrhosis history consistent diagnosis cirrhosis . History gout . History sensitivity study medication , component , opinion investigator GSK Medical Monitor , contraindicate participation . History allergy sulfonamide , sulfonylurea , carbonic anhydrase inhibitor , thiazide , loop diuretic ( ethacrynic acid ) . Subjects clinical laboratory value outside range specify protocol screen Day 1 : Significant ECG abnormality screen accord range specify protocol : Systolic/Diastolic blood pressure : le 80/60 mmHg great 150/95 mmHg screening . Any clinically relevant abnormality identify screen physical laboratory examination . Hemoglobin hematocrit reference range screen Urinary cotinine level indicative smoke history regular use tobacco nicotinecontaining product within 6 month prior screen . The subject positive drug/alcohol test screen check clinic . A minimum list drug screen include amphetamine , barbiturate , cocaine , opiates , cannabinoids , benzodiazepine . History regular alcohol consumption within 6 month study define average weekly intake &gt; 14 drinks/week men &gt; 7 drinks/week woman . One drink equivalent ( 12 g alcohol ) = 5 ounce ( 150 ml ) wine 12 ounce ( 360 ml ) beer 1.5 ounce ( 45 ml ) 80 proof distil spirit . A positive prestudy Hepatitis B surface antigen positive Hepatitis C antibody result within 3 month prior screen . A positive test HIV antibody . The subject participate clinical trial receive investigational product within following time period prior first dose day current study ( whichever longer ) : 30 day , 5 halflives , twice duration biological effect investigational product . Use prescription nonprescription drug , include vitamin , herbal dietary supplement ( include St John 's Wort ) within 7 day ( 14 day drug potential enzyme inducer ) 5 halflives ( whichever longer ) prior first dose study medication , unless opinion Investigator GSK Medical Monitor medication interfere study procedure compromise subject safety . Where participation study would result donation blood blood product excess 500mL within 56 day period . History sensitivity heparin heparininduced thrombocytopenia . History sensitivity latex</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Interaction ,</keyword>
	<keyword>Diabetes ,</keyword>
	<keyword>healthy male subject</keyword>
	<keyword>GSK189075 ,</keyword>
	<keyword>Diuretics ,</keyword>
</DOC>